Picture of Avenue Therapeutics logo

ATXI — Avenue Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Avenue Therapeutics Says Joseph Vazzano Resigning From His Role As CFO

Jan 7 (Reuters) - Avenue Therapeutics Inc  ATXI.O :
    * AVENUE THERAPEUTICS INC - ON JAN 5, 2022, JOSEPH VAZZANO
NOTIFIED CO THAT HE WAS RESIGNING FROM HIS ROLE AS CO'S CFO,
EFFECTIVE JAN 14, 2022
    * AVENUE THERAPEUTICS INC - VAZZANO DID NOT RESIGN AS A
RESULT OF
ANY DISAGREEMENT WITH THE COMPANY
    * AVENUE THERAPEUTICS INC - ON JAN 7, 2022 CO APPOINTED LUCY
LU,
AS CO'S INTERIM CHIEF FINANCIAL OFFICER AND PRINCIPAL FINANCIAL
OFFICER

Source: (https://bit.ly/3F5orUj)
Further company coverage:  ATXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avenue Therapeutics

See all news